01 7Kisqali
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 687
2019 Revenue in Millions : 480
Growth (%) : 43
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 937
2020 Revenue in Millions : 687
Growth (%) : 36
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,231
2021 Revenue in Millions : 937
Growth (%) : 31
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 2,080
2022 Revenue in Millions : 1,231
Growth (%) : 69
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 76
2016 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 235
2017 Revenue in Millions : 76
Growth (%) : 209%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 480
2018 Revenue in Millions : 235
Growth (%) : 104
LOOKING FOR A SUPPLIER?